banner
Journal of Neuroinflammation and Neurodegenerative Diseases

Manuscript submission window open for Volume 3


  • About Journal
  • Focus & Scope
  • Editor in Chief
  • Editorial Board
  • Articles
  • Submit Manuscript
  • Article Processing Charges

Journal of Neuroinflammation and Neurodegenerative Diseases (JNND) is a multidisciplinary international scholarly journal that focuses on rending a platform for researchers to disseminate knowledge on advances in the understanding all the disciplines of neuroinflammation and neurodegenerative diseases. Articles are welcome in the form of original research, reviews, case reports, commentaries, perspectives, hypothesis, short communications, letter to editors, mini-reviews etc.

The manuscripts submitted to the journal will be sent out for a thorough peer review by the experts within the scope of the manuscript and the first decision will be provided to authors approximately within 28 days from the date of submission. Minimum two independent reviewer’s approval and an editor approval is taken into consideration for acceptance or rejection of a manuscript.

Authors are requested to submit their manuscripts online at submit manuscript or send as an email attachment to the editorial office at submissions@onjourn.org

All the articles Published in Journal of Neuroinflammation and Neurodegenerative Diseases will be distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

Focus

The main focus of Journal of Neuroinflammation and Neurodegenerative Diseases (JNND) is disseminating the knowledge on interactions of the immune system with the nervous system and all neurodegenerative diseases.

Scope

The major areas of interest for the journal includes but not limited to

  • Alexander disease
  • Alzheimer’s disease
  • Amyotrophic lateral sclerosis
  • Batten disease
  • Creutzfeldt-Jakob disease
  • Dentatorubralatrophy
  • Friedreich’s ataxia
  • Frontotemporal dementia
  • Hallervorden-Spatz disease
  • Huntington’s disease
  • Interactions of the immune system
  • Lewy body disease
  • Motor neurone diseases
  • Neuronal ceroid lipofuscinosis
  • Parkinson’s disease
  • Prion disease
  • Roles of CNS immune mediators
  • Spinal muscular atrophy

Will be updated soon...

Editorial Board

Theresa A. Zesiewicz, Professor, Department of Neurology, Director of USF Ataxia Research Center, The Frances J. Zesiewicz Foundation for Parkinson's Disease at USF, Parkinson's Disease and Movement Disorders Clinic at the PADREC, USA

Nikolaos K. Robakis, Professor of Psychiatry, Neuroscience and experimental therapeutics, First A.P. Slaner family Professor for Alzheimer disease research, Icahn School of Medicine at Mount Sinai, USA

Frank C Barone, Professor of Neurology and Physiology & Pharmacology, Director of Basic Research, Cerebrovascular Division, SUNY Downstate Medical Center, USA

Wei Cao, Associate Professor, Huffington Center On Aging, Baylor College of Medicine, USA

Junming Wang, Associate Professor, Adjunct Faculty, Psychiatry and Human Behavior; Memory Impairment and Neurogenerative Dementia (MIND Center), Pharmacology and Toxicology, University of Mississippi Medical Center, USA

Ulrich L. M. Eisel, Associate Professor, Department of Molecular Neurobiology, The University of Groningen, The Netherlands

Timothy A. Collins, Associate Professor, Chief, Headache Division, Department of Neurology, Duke University Medical Center, USA

Hongzhen Hu, Associate Professor, Department of Anesthesiology, Washington University School of Medicine in St. Louis, USA

Majid A.Khan, Associate Professor , Department of Radiology and Neurology/Neurosciences, Chief, Division of Neuroradiology, University of Mississippi Medical Center, USA

Santiago D. Toledo, Medical Director, Parkinson’s disease and movement disorders, Shirley Ryan AbilityLab, USA; Assistant Professor, Department of Physical Medicine & Rehabilitation and Department of Neurology, Northwestern University Feinberg School of Medicine, USA

Michelle Hook, Assistant Professor, Department of Neuroscience and Experimental Therapeutics, Interdisciplinary Program in Neuroscience, Texas A&M College of Medicine, USA

Rwoof Ahmed Reshi, Assistant Professor, Department of Department of Neurology, University of Minnesota, USA

Derrick Robertson, Assistant Professor, Director, Multiple Sclerosis Division, Department of Neurology, University of South Florida, Morsani College of Medicine, USA

Chetan Gandhy, Assistant Professor, Department of Neurology, James A. Haley Veteran's Hospital, University of South Florida, USA

Xiaoyan Sun, Assistant Professor, Department of Neurology, Evelyn F McKnight Brain Institute, University of Miami Miller School Medicine, USA

Tatyana Gitlevich, Assistant Professor, The Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, USA

Dongming Cai, Assistant Professor, Department of Neurology & Ronald M. Loeb Center for Alzheimer's Disease, USA

Aimee F. Luat, Assistant Professor of Pediatrics and Neurology, Department of Neurology, Wayne State University, USA

Rahul Damani, Assistant Professor, Division of Vascular Neurology & Neurocritical Care, Department of Neurology, Baylor College of Medicine, USA

  • In Press
  • Current Issue
  • Archive

Articles in Press (Volume 3 Issue 1)


  • Open Access Commentary

    Beyond Aducanumab and the Amyloid Hypothesis

    Authored by: Wei Cao

    View PDF

Current Issue (Volume 2, Issue 1)


  • Open Access Case Report

    Combined Endoscopic Transorbital and Endonasal Repair of High Flow Orbital Apex/Middle Fossa Cerebrospinal Fluid Leak with a Nasoseptal Flap

    Authored by: Brandon Lucke-Wold, Gustavo Mendez, David Cua, Paul Akins, Haley Gillham, and Jeremy Ciporen

    View PDF View as HTML Supplementary File

  • Open Access Review Article

    Educational Success of African Americans with Autism: An Exploratory Study

    Authored by: Tremaine Riley, Shanika L. Wilson, and Christopher Solomon

    View PDF View as HTML

  • Open Access Research Article

    Temporal Changes in Tau Phosphorylation and Related Kinase and Phosphatases Following Two Models of Traumatic Brain Injury

    Authored by: Lyndsey Collins-Praino, Daniel Gutschmidt, Jessica Sharkey, Alina Arulsamy, and Frances Corrigan

    View PDF View as HTML

Submit Manuscript

We request you to submit the manuscript through submission form below. Note that all the fields marked* are mandatory. Please also include the full abstract that will help the reviewers to rapidly decide if your paper enters their domain of expertise or not. Also, we request you to submit appropriate keywords of the article to help the editors to assign your paper to the correct reviewers. Acknowledgement of the submitted manuscript will be mailed to corresponding author between 24-48 hours. If you feel any difficulty in submitting the manuscript through online submission system, you may email the manuscript directly to our editorial office at: submissions@onjourn.org


Author Details





Article Details




(Cover Letter, Manuscript, Figures, Tables, Supplementary Files)
Add More Attachments

Article Processing Charges

All the manuscripts submitted to Onjourn Publishers are assumed to be submitted under the open access publishing model. Being an open access publisher, we do not collect any subscription charges and allow the readers free access to all its articles. The manuscripts submitted to the journal will be peer reviewed similar way as in subscription model under the control of editorial board members. If the article is found to be acceptable for publishing in a particular journal then the author will be issued with an invoice for payment of article publishing charges. These charges are used as offset expenses for peer review management, journal production and online hosting and archiving. The article publishing charges for the articles accepted for publication in Journal of Neuroinflammation and Neurodegenerative Diseases that are to be paid upon acceptance are


Journal Name Fee (GBP)
Journal of Neuroinflammation and Neurodegenerative Diseases 937